FDA: Prenatal use of antipsychotics might pose risk to newborns - Related Stories - AAP SmartBrief

Links shared publicly online about this topic.

  • 485
    total visits

FDA: Prenatal use of antipsychotics might pose risk to newborns - Related Stories - AAP SmartBrief

smartbrief.com

The FDA warned that taking atypical antipsychotics during the third trimester of pregnancy might cause abnormal muscle movement and withdrawal symptoms among newborns. The warning label for such drugs was upgraded to mention the risk, the agency said.

View full resource at smartbrief.com

Tags: Muscle, Children's Health, Pregnancy, Relationship, FDA, American Academy of Pediatrics

  • Share

Most Recently Shared on February 23, 2011 at 7:09 pm By:

nataliehodge Natalie Hodge, MD, FAAP

FDA: Prenatal use of antipsychotics may pose risk newborns http://sbne.ws/r/6Qke True, but I also hate actively psychotic pregnant mothers

1 year ago...

Advertisement